Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MRPL13 Act as a Novel Therapeutic Target and Could Promote Cell Proliferation in Non-Small Cell Lung Cancer

1 Jul 2021

Abstract excerpt

BACKGROUND: The latent involvement of MRPL13 in non-small cell lung cancer (NSCLC) remains unclear. This study aimed to explore the role of MRPL13 in NSCLC. METHODS: All analyses were performed in R software 4.0, SPSS version 23, and GraphPad Prism 8. The "limma" package was used to identify differentially expressed genes. Univariate and multivariate cox analyses were used to identify prognosis-related genes....

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Clusterin in disease pathology
Share to Ferroptosis and cancer prognosis
Share to Immune cells in cancer

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34285575
DOI: 10.2147/cmar.s316428

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MRPL13 Act as a Novel Therapeutic Target and Could Promote Cell Proliferation in Non-Small Cell Lung CancerPMID 34285575Read ↗

Overexpression of MRPL19 in predicting poor prognosis and promoting the development of lung adenocarcinomaSemantic proximity Read ↗

Prognostic Value and Related Regulatory Networks of MRPL15 in Non-Small-Cell Lung CancerSemantic proximity Read ↗

Pan-cancer analysis of the oncogenic effects of ribosomal protein L13 (MRPL13) and validation in hepatocellular carcinomaSemantic proximity Read ↗

Identification of the Upregulation of MRPL13 as a Novel Prognostic Marker Associated with Overall Survival Time and Immunotherapy Response in Breast Cancer.Semantic proximity Read ↗

MRPL13 Promotes Tumor Cell Proliferation, Migration and EMT Process in Breast Cancer Through the PI3K-AKT-mTOR PathwaySemantic proximity Read ↗

A multidimensional analysis of MRPL17 protein in human tumorsSemantic proximity Read ↗

Mitochondrial ribosomal protein L3 (MRPL3): An early diagnostic biomarker and potential molecular target in pancreatic cancerSemantic proximity Read ↗

TRIP13 promotes lung cancer cell growth and metastasis through AKT/mTORC1/c-Myc signalingSemantic proximity Read ↗

Integrated analysis reveals critical cisplatin-resistance regulators E2F7 contributed to tumor progression and metastasis in lung adenocarcinomaSemantic proximity Read ↗

Exploring the function and prognostic value of RPLP0, RPLP1 and RPLP2 expression in lung adenocarcinomaSemantic proximity Read ↗

Long non-coding RNA LSAMP-1 is down-regulated in non-small cell lung cancer and predicts a poor prognosisSemantic proximity Read ↗

UBASH3B-mediated MRPL12 Y60 dephosphorylation inhibits LUAD development by driving mitochondrial metabolism reprogrammingSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.